64Cu-LLP2A for Imaging Multiple Myeloma

NCT03804424 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped Drug formulation changed, opening new trial

Conditions

Multiple Myeloma

Interventions

DRUG: 64Cu-LLP2A
DEVICE: PET/MR
PROCEDURE: Blood samples for serum stability
PROCEDURE: Blood samples for metabolite analysis
PROCEDURE: Urine sample
PROCEDURE: Tumor biopsy
PROCEDURE: Electrocardiogram
DEVICE: PET/CT

Sponsor

Washington University School of Medicine